Rezolute, Inc. (RZLT) stock
RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
$4.25+0.24 (+5.85%)
Close on Nov 18, 2026Market cap $411.07MP/E –Yield –
Rezolute operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Rezolute's operating cash flow for the twelve months ending Sep 30, 2026 was -$65.95M. For fiscal 2026 it was -$64.60M. The highest annual figure on record is -$363.22K in fiscal 2011.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$64.60M | – |
| FY2025 | Jun 30, 2025 | -$69.08M | – |
| FY2024 | Jun 30, 2024 | -$57.37M | – |
| FY2023 | Jun 30, 2023 | -$44.48M | – |
| FY2022 | Jun 30, 2022 | -$39.62M | – |
| FY2021 | Jun 30, 2021 | -$20.44M | – |
| FY2020 | Jun 30, 2020 | -$24.17M | – |
| FY2019 | Jun 30, 2019 | -$15.30M | – |
| FY2018 | Jun 30, 2018 | -$14.11M | – |
| FY2017 | Jun 30, 2017 | -$13.31M | – |
| FY2016 | Jun 30, 2016 | -$10.49M | – |
| FY2015 | Jun 30, 2015 | -$7.08M | – |
| FY2014 | Jun 30, 2014 | -$3.17M | – |
| FY2011 | Dec 31, 2011 | -$363.22K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | -$18.78M | – |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$13.11M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$13.74M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$20.32M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$17.43M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$22.00M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$17.40M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$13.67M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$16.01M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$18.52M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$15.24M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$13.02M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$10.59M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$11.35M | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$18.05M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$7.49M | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$7.59M | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$12.11M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$13.97M | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$7.20M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$6.34M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$5.23M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$5.40M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$6.26M | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$3.55M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$4.08M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$5.68M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$5.48M | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -$8.93M | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$3.88M | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$2.18M | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$3.15M | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$4.91M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$3.64M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$3.61M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$3.09M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$2.97M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -$3.15M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -$2.54M | – |
See a number that looks wrong?